[FEDERAL CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS, PREVENTION AND TREATMENT OF PNEUMOCONIOSIS].

The purpose of development of this clinical practice guidelines was to provide evidence-based protocols that help the practitioner and the patient make the right decision for the health assessment, treatment and prevention of pneumoconiosis. Pneumoconiosis is the interstitial lung disease of occupational origin caused by prolonged inhalation of inorganic dust, characterized by chronic diffuse aseptic inflammation in lung tissue with the development of pulmonary fibrosis. Currently, thereare no treatment that provide a cure pulmonary fibrosis and changes in the dynamics of decline in lung function.

[Irumamicin Produced by Streptomyces roseoflavus INA-1278].

The strain Streptomyces roseoflavus INA-1278 is described as a new irumamicin producer. Irumamicin 1278 is different by the antifungal activity from irumamicin produced by the world-known strain Streptomyces subflavus subsp. Irumaensis subps.

[The problems of classification of the occupational interstitial lung diseases, approaches to solving].

The analysis of the applied in Russia classifications of pneumoconiosis and occupational hypersensitivity pneumonitis in relation to the international classifications of occupational lung diseases and the classification of interstitial lung diseases (ILD) was performed. The necessity of a new approach to the classification of occupational ILD was proved and solutions of the problem were offered.